Hormonal contraception and skin – detailed study notes

Hormonal contraception and skin – study notes

• General context

  • This module discusses how hormonal contraception can affect the skin and why providers should present information to clients to support informed choices.
  • Hormonal contraception is a form of synthetic hormones and can have broad effects on the body, including the skin.
  • Ethical/practical stance shared: clients should make their own decisions after being fully informed; the clinician’s personal opinion is not presented as a directive.
  • Real-world relevance: many clients have undergone long pathways through GP or dermatologist appointments seeking skin improvements via contraception.
  • Important caveat emphasized: the discussion is about effects on the skin among other body systems, not a medical endorsement for or against contraception.

• Basic hormonal contraception overview

  • Common hormonal contraceptives include pills, implants, and IUDs (coils).
  • A hormonal contraceptive typically contains synthetic estrogens and/or progestins (synthetic progesterone).
  • Effects on the skin are often linked to the influence of sex hormones.
  • Progestin can either mimic or block androgens; the net effect on the skin depends on the specific progestin component.
  • Estrogens (even when synthetic) can counteract some acne-related side effects, though this is not universal.

Combined oral contraceptive pill (COC)

• Definition and general use
  • The most common contraceptive is the combined oral contraceptive pill (COC): a pill containing both estrogen and progestin (synthetic).
  • Taken once daily with a typical regimen of a 7-day break between cycles.
  • Contains both synthetic estrogen and synthetic progestin.
• Progestin effects on skin
  • Progestin can either mimic or block androgens (androgenic vs anti-androgenic effects).
  • Anti-androgenic progestins can block androgen receptors, which may reduce oiliness and acne in some clients.
• Notable brands and progestin types
  • Yaz / Yasmin: contain drospirenone, a progestin with anti-androgenic properties (blocks androgen receptors).
  • Why it matters for skin: helpful for people with excess oil, sebum production, or acne due to androgen activity.
  • Other common progestins in COC: nominals such as norethindrone and levonorgestrel can mimic androgens.
  • If a COC contains norethindrone or levonorgestrel, it may increase oil production and acne risk for some individuals with higher baseline androgens.
• Practical implications for acne-prone clients
  • For clients with acne-prone skin, some doctors may consider anti-androgenic progestins as a preferred option within the COC class.
  • A COC that contains progestins with androgenic activity can worsen oiliness and acne in some patients.
• Summary points for COC decision-making
  • If acne is a primary concern, discuss potential anti-androgenic options (e.g., drospirenone-containing formulations).
  • If the patient has a history of oily skin or acne, weigh the androgenic potential of the chosen progestin.
  • Always balance skin considerations with other health risks (blood clots, cardiovascular risk) in decision-making.

Progestin-only pills (POPs)

• What they are
  • Progestin-only pills (POPs) are a separate class of daily pills without an estrogen component.
  • Typically prescribed when estrogen exposure is undesirable or contraindicated.
• Common prescribing patterns
  • On the NHS, norethindrone and levonorgestrel have historically been among the cheaper options, and are progestins that can mimic androgens.
  • Some clinicians may skip combined methods for patients with family history of breast cancer, clot risk, or other contraindications, replacing with POPs.
• How POPs relate to skin
  • Progestins can mimic or block androgens; their impact on skin varies by formulation.
  • The potential for oil production or acne may be influenced by the specific progestin’s androgenic activity.
• Cautions highlighted
  • While cost and accessibility matter in real-world prescribing, there is concern that some POPs (e.g., norethindrone or levonorgestrel-containing formulations) may worsen androgenic skin effects for some individuals.
  • The speaker emphasizes that providers should consider the full hormonal profile and patient history rather than default to POPs in all cases.

Depot injection (Depo-Provera) and other injectable methods

• Depot/injection overview
  • Injections (depot injections) release medroxyprogesterone acetate (a synthetic progestin) locally and systemically.
  • Administered in the lower back or upper buttocks.
  • The impact is long-lasting: the dose remains in the body for between $3$ to $6$ months depending on the brand ($3$-$6$ months).
  • Reversal of the effect is not possible once injected.
• Skin and hair follicle implications
  • Progestins can mimic or block androgens; they can shrink hair follicles and influence oil production.
  • When higher androgen activity is present, progestin can exacerbate acne or oiliness in some clients.
• Acne considerations and challenges
  • The Depo injection is widely known to trigger acne in susceptible individuals.
  • If acne flares after injection, improvement may not be seen until the hormone dose has waned and the drug is cleared from the system.
• Management notes
  • Clinically, treatments can help acne temporarily, but significant improvement is often tied to the clearance of the drug from the body.

Implants

• What an implant is
  • A small plastic stick inserted into the front of the bicep or the back of the arm (tricep area).
  • It releases etonogestrel—a progestin—for ongoing contraception.
• Duration and hormonal impact
  • Effective for between $3$ to $5$ years.
  • Continuously delivers synthetic progestin, which can mimic or block androgens and shrink hair follicles, potentially increasing oil production.
• Practical considerations
  • Although effective, removal or replacement can be a traumatic experience for some people.
  • If clients already have an implant, clinicians should consider whether skin concerns may be linked to this method.
• Removal and replacement
  • Implants can be removed, but the process and hormonal effects may persist for a while depending on individual physiology.

Hormonal intrauterine devices (IUDs) and coils

• Hormonal IUD basics
  • Hormonal IUDs release levonorgestrel locally into the uterus, which enters the bloodstream more rapidly than expected due to the local release pattern.
  • They are effective for long durations and are a local delivery system.
• Skin implications
  • Leverage of levonorgestrel is androgenic and can worsen acne because it increases oil production and can shrink follicles.
  • The rapid entry of levonorgestrel into the bloodstream contributes to acne flare risks for some individuals.
• Practical considerations for acne-prone clients
  • Hormonal IUDs are noted in clinical experience as a common trigger of hormonal acne.
  • If skin issues are triggered, removal is advised as a potential remedy; once removed, acne may improve as the hormonal influence ceases.
• Removal and expectations
  • If a patient chooses to remove the hormonal IUD due to acne, stopping the local release typically leads to a decrease in androgenic signal to the skin and potential improvement in acne.
  • If the patient decides to keep the device for personal/trauma-related reasons, acne may continue to be a persistent issue due to ongoing levonorgestrel exposure.

Copper IUD

• Brief note
  • Copper coils are non-hormonal; they function differently from hormonal IUDs and were not the focus of this module beyond contrast.
• Relevance to acne/skin
  • The module centers on hormonal methods and their impact on skin; copper IUDs do not release hormones and thus have a different dermatological risk profile.

Acne, skin health, and contraceptive choices

• Practical recommendations for acne-prone clients
  • Generally, progestin-only methods are less favorable for acne-prone patients due to potential androgenic activity.
  • Estrogen-containing options can counteract acne side effects, but decisions must balance skin benefits with other health risks.
• Provider mindset for acne management
  • For acne-prone clients, an estrogen-containing approach may be considered if clinically appropriate.
  • In many cases, clinicians may favor non-hormonal or carefully chosen hormonal options to minimize acne risk.
• Overall clinical strategy
  • For each client, present all options with their skin-related implications, then support informed decision-making.

Ethical, practical, and real-world implications

• Patient autonomy and informed consent
  • The emphasis is on sharing comprehensive information and enabling clients to decide for themselves.
  • Clinicians should avoid pressuring clients into a particular contraceptive method.
• Weighing skin outcomes against broader health factors
  • Acne and oil production are important considerations but must be weighed against risks like blood clots, cardiovascular effects, and breast cancer history.
• Personal perspectives vs evidence
  • While the clinician cites a personal view that synthetic hormones could be avoided, decisions should be grounded in evidence and patient preferences.
• Role of mind maps and future modules
  • A mind map in a subsequent module will explore causal links and reasoning for how and why various hormonal options affect the body, including the skin.

Takeaway messages and practical tips for exam preparation

• Expect questions on:

  • The mechanisms by which estrogen and progestin influence skin (androgen receptor interactions).
  • How specific progestins differ in androgenic vs anti-androgenic activity (e.g., drospirenone vs norethindrone/levonorgestrel).
  • The major hormonal contraception options and their typical durations and routes (COC, POPs, DMPA injection, implant, hormonal IUD, copper IUD).
  • How acne-prone skin should influence contraceptive choice and management strategies.
  • The ethical emphasis on patient autonomy and informed decision-making.

• Quick reference numbers

  • Pill break: 7 days between cycles -> "$7$-day break".
  • Depot duration: between $3$ and $6$ months per dose -> "$3$-$6$ months".
  • Implant duration: $3$-$5$ years.
  • Acne impact timelines: acne can flare with certain hormones and may improve after removal of the offending method.

• Key terms to memorize

  • Combined oral contraceptive pill (COC)
  • Progestin-only pill (POP)
  • Drospirenone (a.k.a. ethinodrolone? note: commonly Drospirenone; anti‑androgenic)
  • Norethindrone, Levonorgestrel (androgenic progestins)
  • Etonogestrel (implant)
  • Medroxyprogesterone acetate (DMPA; depot injection)
  • Levonorgestrel (in hormonal IUD and IUD formulations)
  • Anti‑androgenic vs androgenic effects

• Final note

  • The module encourages giving clients all information and supporting an informed decision, recognizing that societal attitudes toward hormonal contraception are evolving and that current research covers broader health impacts beyond skin, including gut and mental health.